Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-902.93%
operating margin TTM
-916.0%
revenue TTM
3.11 Million
revenue per share TTM
0.06$
valuation ratios | |
|---|---|
| pe ratio | -0.11 |
| peg ratio | -0.02 |
| price to book ratio | 0.68 |
| price to sales ratio | 0.98 |
| enterprise value multiple | 1.30 |
| price fair value | 0.68 |
profitability ratios | |
|---|---|
| gross profit margin | -59.81% |
| operating profit margin | -916.0% |
| pretax profit margin | -902.93% |
| net profit margin | -902.93% |
| return on assets | -47.86% |
| return on equity | -213.14% |
| return on capital employed | -57.68% |
liquidity ratio | |
|---|---|
| current ratio | 1.61 |
| quick ratio | 1.61 |
| cash ratio | 1.26 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 21.91 |
| days of payables outstanding | 40.46 |
| cash conversion cycle | -18.54 |
| receivables turnover | 16.66 |
| payables turnover | 9.02 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.84 |
| debt equity ratio | 11.10 |
| long term debt to capitalization | 0.50 |
| total debt to capitalization | 0.92 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -0.43 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.05 |
| cash per share | 0.55 |
| operating cash flow per share | -1.01 |
| free cash flow operating cash flow ratio | 1.04 |
| cash flow coverage ratios | -0.43 |
| short term coverage ratios | -13.90 |
| capital expenditure coverage ratio | -27.01 |
Frequently Asked Questions
When was the last time Omega Therapeutics, Inc. (NASDAQ:OMGA) reported earnings?
Omega Therapeutics, Inc. (OMGA) published its most recent earnings results on 14-11-2024.
What is Omega Therapeutics, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Omega Therapeutics, Inc. (NASDAQ:OMGA)'s trailing twelve months ROE is -213.14%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Omega Therapeutics, Inc. (OMGA) currently has a ROA of -47.86%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did OMGA's net profit margin stand at?
OMGA reported a profit margin of -902.93% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is OMGA's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.61 in the most recent quarter. The quick ratio stood at 1.61, with a Debt/Eq ratio of 11.10.